Old Web
English
Sign In
Acemap
>
Paper
>
The development of a potent, KDR/VEGFR2-sparing RET kinase inhibitor for treating patients with RET-dependent cancers
The development of a potent, KDR/VEGFR2-sparing RET kinase inhibitor for treating patients with RET-dependent cancers
2016
Barbara J. Brandhuber
Julia Haas
Brian B. Tuch
Kevin Ebata
Karyn Bouhana
E. McFaddin
Lance A. Williams
Shannon L. Winski
Eric J. Brown
M. Burkhard
Nisha Nanda
R. Hamor
Francis J. Sullivan
Lauren Hanson
Tony Morales
Guy Vigers
R. D. Wallace
James F. Blake
Steven W. Andrews
Stephen M. Rothenberg
Keywords:
Immunology
VEGF receptors
Kinase
Medicine
Cancer research
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
8
Citations
NaN
KQI
[]
map